Shin Min Soo, Kang Eun Hwa, Lee Young Ik
Liver Cell Signal Transduction Laboratory, Bioscience Research Division, Korea Research Institute of Bioscience and Biotechnology, Taejon 305-606, Republic of Korea.
Antiviral Res. 2005 Sep;67(3):163-8. doi: 10.1016/j.antiviral.2005.06.005.
A flavonoid molecule that showed a unique anti-HBV function was isolated from Phyllanthus urinaria. The molecular formula was determined as C14H6O8 based on FAM-MS analysis and the structure was determined by NMR. The identified flavonoid molecule, ellagic acid, showed unique anti-HBV functions. Ellagic acid did not inhibit either HBV polymerase activity, HBV replication or block HBsAg secretion. Rather, ellagic acid blocks effectively HBeAg secretion in HepG2 2.2.15 cells (IC50=0.07 microg/ml). Since HBeAg is involved in immune tolerance during HBV infection, ellagic acid, a newly identified functional anti-HBV compound, may be a new candidate therapeutic against immune tolerance in HBV-infected individuals.
从叶下珠中分离出一种具有独特抗乙肝病毒功能的黄酮类分子。基于FAM-MS分析确定其分子式为C14H6O8,并通过核磁共振确定其结构。鉴定出的黄酮类分子鞣花酸具有独特的抗乙肝病毒功能。鞣花酸既不抑制乙肝病毒聚合酶活性、乙肝病毒复制,也不阻断乙肝表面抗原的分泌。相反,鞣花酸能有效阻断HepG2 2.2.15细胞中乙肝e抗原的分泌(IC50 = 0.07微克/毫升)。由于乙肝e抗原参与乙肝病毒感染期间的免疫耐受,鞣花酸作为一种新鉴定出的具有抗乙肝病毒功能的化合物,可能是治疗乙肝病毒感染个体免疫耐受的新候选药物。